Natus to Acquire Neurosurgery Assets from Integra LifeSciences, Enters Neurosurgery Market
Sep 11, 2017 11:30 am UTC| Business
Expands Natus product offering into neurosurgery marketExpects acquisition to be immediately accretive to non-GAAP earningsAssets include Camino ICP monitoring product line and associated products PLEASANTON, Calif.,...
U.S. Cybersecurity Policy Director Joins FTI Consulting
Sep 11, 2017 11:30 am UTC| Business
Cheryl Davis Joins from the U.S. National Security Council Government and International Policy Experience Enhances FTI Consulting’s Cybersecurity Offering WASHINGTON, Sept. 11, 2017 -- FTI Consulting, Inc....
Sep 11, 2017 11:30 am UTC| Business
BELLEVUE, Wash., Sept. 11, 2017 -- J. Braxton Carter, Executive Vice President Chief Financial Officer, and Mike Sievert, Chief Operating Officer of T-Mobile US, Inc. (NASDAQ:TMUS) will present and provide a business...
Sep 11, 2017 11:30 am UTC| Business
Substantial and Durable Anti-Seizure Efficacy Shown in Patients Suffering From Severe, Rare Genetic Epilepsy Marinus to Host Conference Call and Webcast Today at 9:00 am EDT RADNOR, Pa., Sept. 11, 2017 -- Marinus...
EFI Reports Second Quarter 2017 Results
Sep 11, 2017 11:14 am UTC| Business
FREMONT, Calif., Sept. 11, 2017 -- Electronics For Imaging, Inc. (Nasdaq:EFII), a world leader in customer-focused digital printing innovation, today announced its results for the second quarter of 2017. For the...
Galena Biopharma and BioVascular, Inc. Reaffirm GALE-401 Partnership
Sep 11, 2017 11:05 am UTC| Business
SAN RAMON, Calif., Sept. 11, 2017 -- Galena Biopharma, Inc. (NASDAQ:GALE), a biopharmaceutical company developing hematology and oncology therapeutics that address unmet medical needs, today announced it has reaffirmed...
Sep 11, 2017 11:02 am UTC| Business
Phase 1 clinical trial results in healthy subjects support cardiac safety of OBE022 Geneva, Switzerland and Boston, MA - 11 September, 2017 - ObsEva SA (NASDAQ: OBSV), a Swiss biopharmaceutical company focused on...